Global Recombinant Protein Market Size To Grow At A CAGR Of 12.10% In The Forecast Period Of 2023-2028


The ‘Recombinant Protein Global Market Size, Share, Price, Trends, Growth, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global recombinant protein market, assessing the market based on its segments like product types, applications, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the basis of SWOT and Porter’s Five Forces Models.

Recombinant Protein Market Size, Share, Price, Trends, Growth, Key Players, Report and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Historical Market Size (2022): Nearly USD 1.53 Billion
• Forecast CAGR (2023-2028): 12.10%

Recombinant proteins are extracted from a recombinant DNA model that utilise molecular biology methodologies. The essential recombinant DNA is produced with the help of an artificial blend of genetic material from distinct sources, which do not appear in natural surroundings.

Get a Free Sample Report with Table of Contents –

Factors like rising investments in research and development (R&D) activities, the increasing prevalence of prolonged diseases, the surging elderly population, the growing tendency towards biologics and biosimilars, and the introduction of developed recombinant items are driving the global recombinant protein market.

The increasing number of cancer cases is boosting the requirement for recombinant protein therapies. Hence, advancements in cancer treatment are likely to favour the global recombinant protein market.

The growing spending on research activities focused on developing improved treatment options is anticipated to boost the requirement for recombinant protein. Furthermore, favourable initiatives by several market players aimed at developing new drugs are expected to drive the market. Moreover, the growing demand for valuable and reliable medicines and the increasing acceptance of biopharmaceuticals are expected to boost the demand for recombinant protein in the coming years.

Recombinant Protein Industry Definition and Major Segments

Recombinant proteins can be defined as proteins coded by recombinant DNA which is replicated in an appearance transmitter that helps in representation of the gene and interpretation of courier RNA. Alteration of the gene by recombinant DNA technology may result in the extraction of a modified protein. Recombinant protein is a controlled and indigenous protein that is produced in several ways to expand the creation of proteins, alter gene structures, and produce beneficial commercial commodities

Read Full Report with Table of Contents –

Based on product types, the global recombinant protein market can be segmented into:

• Growth Factor and Cytokines
• Hormone
• Enzyme
• Antibody
• Immune Checkpoint Proteins
• Recombinant Regulatory Proteins
• Others

Based on applications, the market is classified into:

• Therapeutic Use
• Research Application
• Biotechnology Industry

The major regional markets of recombinant protein include:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Recombinant Protein Market Trends

Generating protein via recombinant DNA technology offers few considerable benefits, including reduced hazards of resistant response and elevated protein activity. The development of the global recombinant protein market is anticipated to be aided by the rising demand for efficient medications for enhanced treatment of patients. Besides, advancements in medical technology are estimated to boost the development of recombinant protein-based vaccines.

In conjunction with the increasing demand for efficient medicines for various chronic and acute diseases, leading market players and government organisations are funding the progress of novel medicines, which is likely to drive the growth of the global recombinant protein market in the upcoming years.

The growing occurrence of recurring or chronic ailments is expected to expand the demand for recombinant protein owing to their efficacy in treating various diseases. Rising partnerships between key players and research institutions are anticipated to support the progress of the recombinant protein market.

Geographically, North America is anticipated to account for the largest market share due to the increasing number of patients with chronic ailments like cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others. The regional market is expected to grow further with the rising financing in research and development (R&D) activities by leading market players and government organisations.

Key Market Players

The major players in the global recombinant protein market are:

• Abcam PLC
• Thermo Fisher Scientific, Inc.
• Bio-Techne.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• GeneTex, Inc
• Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Related Reports:

Industrial Rubber Market:

Octopus Market:

Dental Insurance Market:

Aerospace Fasteners Market:

Automotive Sun Visor Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Anisha Luccas, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Leave a Reply